Physician profile
Mohammad Kaleem
NPI 1982762712
$2,666.81
in general payments reported to CMS, 2019-2025
17 companies · $1,913 in 2025
The $1,913 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.43 · 2020: $24.04 · 2021: $101 · 2022: $118 · 2023: $264 · 2024: $169 · 2025: $1,913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,225 · Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,225.15 |
| Food and Beverage | $1,121.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,636.74 | 2021-2025 | Micra, Turbohawk |
| Abbott Laboratories | $269.84 | 2021-2025 | Aveir, Diamondback Coronary, Tendril |
| Recor Medical INC | $149.29 | 2025 | Paradise Ultrasound Renal Denervation System |
| Impulse Dynamics (USA) INC. | $128.55 | 2025 | Optimizer |
| Insulet Corporation | $101.74 | 2025 | Omnipod |
| Cordis US Corp. | $91.10 | 2023 | Rain Sheath Transradial |
| Novartis Pharmaceuticals Corporation | $50.06 | 2019 | |
| Boston Scientific Corporation | $49.92 | 2022 | |
| Philips North America LLC | $38.45 | 2020-2022 | |
| Biotronik INC. | $28.61 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $26.90 | 2019-2020 | |
| Cardiva Medical, INC. | $25.56 | 2024 | Optowire |
| W. L. Gore & Associates, INC. | $16.00 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| E.R. Squibb & Sons, L.L.C. | $14.49 | 2024 | Eliquis |
| Merck Sharp & Dohme LLC | $14.36 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13.56 | 2022 | |
| Medtronic Vascular, INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Kaleem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.